Fourth Quarter and Full Year 2016 Financial Results

Feb 28, 2017 — Accelerate Diagnostics filed Fourth Quarter and Full Year 2016 financial results today. Access them directly on our website in the SEC filings section of our Investors page or through the Securities and Exchange Commission’s (SEC) website.

Continue reading


Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit

Feb 24, 2017 — Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples. The blood culture kit is indicated for susceptibility testing of specific pathogenic bacteria commonly associated with bacteremia, the leading cause of sepsis.

Continue reading


Worldwide Antibiotics Awareness Week

Nov 18, 2016 — This week members from the healthcare community worldwide aim to increase awareness about #AntimicrobialResistance led by the World Health Organization and the Centers for Disease Control and Prevention. Accelerate Diagnostics stands with them to share the importance of reducing the misuse and overuse of antibiotics which has become a worldwide public health concern. Learn more […]

Continue reading


Accelerate Diagnostics to Report Third-Quarter 2016 Results on November 9th

Oct 21, 2016 — TUCSON, Ariz., Oct. 21, 2016 (GLOBE NEWSWIRE) — Accelerate Diagnostics, Inc. announced today it will report third-quarter 2016 financial results on Wednesday, November 9, 2016. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will host a conference call to review the results at 4:15 p.m. ET. The quarterly financial […]

Continue reading


See all news
Media kit
Media contact

Andy Chasteen
520.365.3100
achasteen@axdx.com


Company information

About the company
Bios
Our products


Digital assets

Enter your email address below for access to photos, logos and videos.

See Terms and Use Policy


Connect with us

  Like us on Facebook
  Follow us on Twitter
  See us on Linkedin
  Visit us on Google+

Upcoming Events
ISICEM 2017

March 21–27, 2017
Brussels, Belgium

Learn more

Want to hear when we announce our next event?

Stay up to date with Accelerate by joining our mailing list.

Sign up today
Past Events
Reanimation 2017

11 au 13 Janvier 2017
Porte de Versailles a Paris

Learn more

RICAI 2016

12-13 Décembre 2016
Palais des Congrès de Paris

Learn more

SEACM 2016

November 3-5, 2016
Atlanta, GA

Learn more

IDWeek 2016

October 26–30, 2016
New Orleans

Learn more

SWACM 2016

September 7–10, 2016
Fort Worth, TX

Learn more

ASM Microbe 2016

June 16–20, 2016
Boston

Learn more

ECCMID 2016

April 9–12, 2016
Amsterdam

Learn more

Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.

Jun 18, 2016

Reproducibility of the Accelerate ID/AST Blood Culture Assay at Multiple Clinical Sites
ASM 2016

May 01, 2015

Rapid identification and antimicrobial susceptibility testing of bacteria in bloodstream infections using the Accelerate ID/AST technology

Apr 27, 2015

Performance of the new Accelerate ID/AST System in highly resistant Acinetobacter baumannii bloodstream infection isolates, compared to routine laboratory testing

Apr 23, 2015

Performance of the new Accelerate ID/AST System in highly resistant Acinetobacter baumannii bloodstream infection isolates, compared to routine laboratory testing
ECCMID 2015, COPENHAGEN, DENMARK, EPOSTER

See all publications

Get some

Support

Learn about our

Technology